News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 1, 2020

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s)Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Related Content

"FDA" text.

FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC

November 19th 2025

Image of FDA.

FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer

BySpencer Feldman

November 19th 2025

Dr. Benjamin Herzberg spotlighted some of the “weird and wacky” new ideas in the field of targeted therapies for the treatment of lung cancer: © stock.adobe.com.

Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer

November 18th 2025

lungs

Understanding Emerging Cell Therapy in Lung Cancer

November 18th 2025

lung image

Targeted Therapies Are Transforming Lung Cancer Treatment

November 18th 2025

Trending on CURE

FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer

FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC

Finding Gratitude and Love for Cancer Patients and Caregivers

Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer

FDA Grants Fast Track Status to New Gastric Cancer Treatment

© 2025 MJH Life Sciences^®

All rights reserved.